rs712

Variant summary

Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_033360.4(KRAS):​c.*298T>G variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.536 in 1,341,780 control chromosomes in the GnomAD database, including 198,236 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.47 ( 18345 hom., cov: 31)
Exomes 𝑓: 0.54 ( 179891 hom. )

Consequence

KRAS
NM_033360.4 3_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 3.46

Publications

93 publications found
Variant links:
Genes affected
KRAS (HGNC:6407): (KRAS proto-oncogene, GTPase) This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008]
ETFRF1 (HGNC:27052): (electron transfer flavoprotein regulatory factor 1) Involved in respiratory electron transport chain. Located in mitochondrion. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 12-25209618-A-C is Benign according to our data. Variant chr12-25209618-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 40467.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.78 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KRASNM_033360.4 linkc.*298T>G 3_prime_UTR_variant Exon 6 of 6 ENST00000256078.10 NP_203524.1
KRASNM_004985.5 linkc.*177T>G 3_prime_UTR_variant Exon 5 of 5 ENST00000311936.8 NP_004976.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KRASENST00000256078.10 linkc.*298T>G 3_prime_UTR_variant Exon 6 of 6 1 NM_033360.4 ENSP00000256078.5
KRASENST00000311936.8 linkc.*177T>G 3_prime_UTR_variant Exon 5 of 5 1 NM_004985.5 ENSP00000308495.3

Frequencies

GnomAD3 genomes
AF:
0.469
AC:
71110
AN:
151780
Hom.:
18340
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.243
Gnomad AMI
AF:
0.400
Gnomad AMR
AF:
0.492
Gnomad ASJ
AF:
0.625
Gnomad EAS
AF:
0.801
Gnomad SAS
AF:
0.669
Gnomad FIN
AF:
0.542
Gnomad MID
AF:
0.535
Gnomad NFE
AF:
0.541
Gnomad OTH
AF:
0.485
GnomAD4 exome
AF:
0.544
AC:
647866
AN:
1189882
Hom.:
179891
Cov.:
30
AF XY:
0.547
AC XY:
313066
AN XY:
572148
show subpopulations
African (AFR)
AF:
0.226
AC:
5597
AN:
24794
American (AMR)
AF:
0.504
AC:
6171
AN:
12240
Ashkenazi Jewish (ASJ)
AF:
0.639
AC:
10739
AN:
16804
East Asian (EAS)
AF:
0.796
AC:
23351
AN:
29322
South Asian (SAS)
AF:
0.656
AC:
29540
AN:
44998
European-Finnish (FIN)
AF:
0.558
AC:
16892
AN:
30290
Middle Eastern (MID)
AF:
0.558
AC:
1817
AN:
3254
European-Non Finnish (NFE)
AF:
0.538
AC:
526886
AN:
979646
Other (OTH)
AF:
0.554
AC:
26873
AN:
48534
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.486
Heterozygous variant carriers
0
13846
27693
41539
55386
69232
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16374
32748
49122
65496
81870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.468
AC:
71139
AN:
151898
Hom.:
18345
Cov.:
31
AF XY:
0.474
AC XY:
35183
AN XY:
74202
show subpopulations
African (AFR)
AF:
0.244
AC:
10100
AN:
41464
American (AMR)
AF:
0.492
AC:
7507
AN:
15252
Ashkenazi Jewish (ASJ)
AF:
0.625
AC:
2166
AN:
3468
East Asian (EAS)
AF:
0.800
AC:
4144
AN:
5178
South Asian (SAS)
AF:
0.668
AC:
3208
AN:
4802
European-Finnish (FIN)
AF:
0.542
AC:
5690
AN:
10500
Middle Eastern (MID)
AF:
0.534
AC:
157
AN:
294
European-Non Finnish (NFE)
AF:
0.541
AC:
36777
AN:
67920
Other (OTH)
AF:
0.486
AC:
1027
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1788
3575
5363
7150
8938
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
652
1304
1956
2608
3260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.495
Hom.:
2786
Bravo
AF:
0.455
Asia WGS
AF:
0.681
AC:
2365
AN:
3474

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 24552817, 25961464, 26535719) -

Noonan syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Noonan syndrome and Noonan-related syndrome Benign:1
Jul 13, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

RASopathy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.31
CADD
Benign
14
DANN
Benign
0.87
PhyloP100
3.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs712; hg19: chr12-25362552; COSMIC: COSV55614059; API